SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/7857C4B517C72D9149E087B24263B4948982249FF6C92E93593157D53D246C6D098C78A32315D256A113B53E13976650>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/7857C4B517C72D9149E087B24263B4948982249FF6C92E93593157D53D246C6D098C78A32315D256A113B53E13976650
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7857C4B517C72D9149E087B24263B4948982249FF6C92E93593157D53D246C6D098C78A32315D256A113B53E13976650
http://www.w3.org/2000/01/rdf-schema#comment
"findings suggest that the E3 ubiquitin-ligase such as Hakai may be a better target than proteasome for using novel specific inhibitors in tumor subtypes that follow EMT."
xsd:string
http://purl.uniprot.org/uniprot/#_1CDBC22403FB3AED1AC50C53FC5C6BCEB742B000C1B747D578C47D70F56266A1BF3ADB5EF816FD1E8DD0F695292DE217
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/7857C4B517C72D9149E087B24263B4948982249FF6C92E93593157D53D246C6D098C78A32315D256A113B53E13976650
http://purl.uniprot.org/uniprot/B4DDV7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7857C4B517C72D9149E087B24263B4948982249FF6C92E93593157D53D246C6D098C78A32315D256A113B53E13976650
http://purl.uniprot.org/uniprot/#_B4DDV7-mappedCitation-28675930
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7857C4B517C72D9149E087B24263B4948982249FF6C92E93593157D53D246C6D098C78A32315D256A113B53E13976650